期刊文献+

下丘脑区恶性淋巴瘤一例报告并文献复习

原文传递
导出
摘要 目的探讨原发性中枢神经系统淋巴瘤(PCNSL)的临床、影像学、诊断及其治疗和预后。方法对2010年10月收治的1例下丘脑区PCNSL的临床资料进行回顾性分析。结果患者表现为颅内压增高,嗜睡,尿崩的症状,血淋巴细胞比率升高,电解质紊乱,甲状腺激素下降,血催乳素升高。头颅MR显示下丘脑区异常信号,呈T1WI低信号,T2WI高信号,FLAIR高信号,水肿相对较轻。注射GD-DTPA后,可表现为均匀一致增强,为团块样增强,呈"握拳样","脐凹征",病灶边界清楚。病理活检:恶性淋巴瘤。行脑立体定向活检术,确诊后以激素治疗,1个月后停药复发。结论 PCNSL病情进展凶险,预后很差,提高认识,早期诊断和针对性化疗,放疗有助于改善患者的预后,其最佳治疗方案仍在探索之中。
出处 《立体定向和功能性神经外科杂志》 2013年第1期42-45,共4页 Chinese Journal of Stereotactic and Functional Neurosurgery
  • 相关文献

参考文献15

  • 1Maher EA, Fine HA. Primary CNS Lymphoma[J]. Se-min Oncol,1999,26 : 346 -356.
  • 2Helle TL, Britt RH,Colby TV. Primary Lymphoma ofthe central nervous system[J]. J Neurosug, 1984, 60: 94-103.
  • 3Yoshida S,Morii K, Watanabe M,et al. Characteristicfeatures of malignant Lymphoma with central nervoussystem involvement[J]. Surg Neurol, 2000,54(2): 160-164.
  • 4Gallatin VM,Weissman IL,Butchec FL. A cell—surfacemolecule involved in organ— specific homing of Lympho-cytes[J]. Neture,1983,304(5921) :30-34.
  • 5Hochberg FH,Miller DC. Primary central nervous sys-tem Lymphoma[J]. J Neurosurg, 1988,68(6) : 835^853.
  • 6高培毅,林燕,孙波,陆荣庆.原发性脑内恶性淋巴瘤的MRI研究[J].中华放射学杂志,1999,33(11):749-753. 被引量:143
  • 7李滢,隋庆兰.颅内原发性中枢神经系统淋巴瘤的MRI研究[J].临床放射学杂志,2007,26(3):223-226. 被引量:30
  • 8Rvbenstein J,Ferreri AJ,Pittalvqa S. Primany Lympho-ma of the central nervous system: epidemiology, patholo-gy and current approaches to diagnosis,prognosis andtreatment[J]. Leuk Lymphoma, 2008, 49 (Suppl 1):43-51.
  • 9Shibamoto Y,oqino H,Suzvki G,et al. Primary centralnervous system Lymphoma in Japan: changes in clinicalfeatures, treatment, and prognosis during 1985 -2004[J]. Neuro Oncol,2008,10(4) :560-568.
  • 10朱艳云,胡毅.原发中枢神经系统淋巴瘤治疗及预后研究进展[J].中华保健医学杂志,2008,10(3):226-230. 被引量:3

二级参考文献63

  • 1李明洙,罗力,高乃康,富春雨,窦长武,王涛,李云霞.原发性颅内淋巴瘤分型及治疗[J].中华神经外科杂志,2006,22(4):259-260. 被引量:30
  • 2[1]Abrey L,DeAngelis LM,Yahalom J.Long-term survival in primary CNS lymphoma[J].J Clin Oncol,1998,16:859-863.
  • 3[2]Pirotte B,Levevier M,Golmann S,et al.Glucocortieoid treatment of primary CNS lymphoma[J].J Neurooncol,1997.32:63-69.
  • 4[3]O'Neill BP,Habermann TM,Witzig TE,et al.Prevention of recurrence and prolonged survival in primary central nervous system lymphoma (PCNSL) patients treated with adjuvant high-dose methylprednisolone[J].Med Oncol,1999,16:211-215.
  • 5[4]Kawakami Y,Tabuchi K,Ohnishi R,et al.Primary central nervoussystem lymphoma[J].J Neurosurg,1985,62:522.
  • 6[5]Nelson DF,Martz KL,Bonner H,et al.Non-Hodgkin lymphoma of the brain:can high-dose,large volume radiation therapy improves survival? Report on a prospective trial by the Radiation Therapy Oncoflogy Group(RTOG)RTOG 83-15[J].Int J Radiat Oncol Biol Phys,1992,23:9-17.
  • 7[6]Brandes AA,Rigon A,Monfardini S.Radiotherapy of the brain in elderly patients contea[J].Eur J Cancer,2000,36:447-451.
  • 8[7]Whitcup SM,de-Smet MD,Rubin BJ,et al.Intraocular lymphoma:Clinical and histopathological diagnosis[J].Ophthalmology,1993,100:1399-1406.
  • 9[8]Schultz C,Scott C,Sherman W,et al.Preirradiation chemotherapy with cyclophosphamide,doxorubicin,vincristine and dcxamethasone for primary CNS lymphomus:Initial report of Radiation Therapy Oncology Group Protocol 88-06[J].J Clin Onco1,1996,14:556-564.
  • 10[9]Mead GM,Bleehen NM,Gregor A,et al.A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma:Cerebral radiotherapy with and without cyclophosphamide,doxorubicin,vincristine and prednisone chemotherapy[J].Cancer,2000,89:1359-1370.

共引文献201

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部